Can ADCs broaden the treatment landscape of metastatic ER+/HER2− breast cancer resistant to CDK4/6 inhibition?
@article{ATM110810, author = {Karen Van Baelen and Christine Desmedt and Hans Wildiers and Patrick Neven}, title = {Can ADCs broaden the treatment landscape of metastatic ER+/HER2− breast cancer resistant to CDK4/6 inhibition?}, journal = {Annals of Translational Medicine}, volume = {11}, number = {6}, year = {2023}, keywords = {}, abstract = {}, issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/110810} }